Creative Planning’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-15,100
| Closed | -$5K | – | 5100 |
|
|
2016
Q3 | $5K | Sell |
15,100
-8,000
| -35% | -$2.65K | ﹤0.01% | 3938 |
|
|
2016
Q2 | $11K | Hold |
23,100
| – | – | ﹤0.01% | 3226 |
|
|
2016
Q1 | $31K | Sell |
23,100
-6,000
| -21% | -$8.05K | ﹤0.01% | 2446 |
|
|
2015
Q4 | $43K | Sell |
29,100
-15,500
| -35% | -$22.9K | ﹤0.01% | 2245 |
|
|
2015
Q3 | $70K | Buy |
44,600
+29,000
| +186% | +$45.5K | ﹤0.01% | 1818 |
|
|
2015
Q2 | $27K | Buy |
15,600
+1,600
| +11% | +$2.77K | ﹤0.01% | 1058 |
|
|
2015
Q1 | $19K | Buy |
14,000
+3,500
| +33% | +$4.75K | ﹤0.01% | 2783 |
|
|
2014
Q4 | $16K | Hold |
10,500
| – | – | ﹤0.01% | 2836 |
|
|
2014
Q3 | $22K | Sell |
10,500
-70
| -0.7% | -$147 | ﹤0.01% | 2502 |
|
|
2014
Q2 | $32K | Buy |
10,570
+370
| +4% | +$1.12K | ﹤0.01% | 2188 |
|
|
2014
Q1 | $26K | Sell |
10,200
-5,580
| -35% | -$14.2K | ﹤0.01% | 2237 |
|
|
2013
Q4 | $78K | Buy |
15,780
+6,500
| +70% | +$32.1K | ﹤0.01% | 1341 |
|
|
2013
Q3 | $21K | Buy |
9,280
+8,000
| +625% | +$18.1K | ﹤0.01% | 2090 |
|
|
2013
Q2 | $3K | Buy |
+1,280
| New | +$3K | ﹤0.01% | 2794 |
|
Creative Planning's RXII Position: Q4 2016 in Review
Creative Planning sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 15,100 shares — an estimated $5K sold.
Creative Planning first reported a position in RXII in Q2 2013 and held it in 14 quarters. The position peaked at $78K in Q4 2013. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.
- Creative Planning reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
- Creative Planning sold 15,100 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $5K.
- Creative Planning first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 14 quarters.
- Creative Planning's GALENA BIOPHARMA INC COM position peaked at $78K in Q4 2013.
- 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.
Based on Creative Planning's 13F filing for Q4 2016, filed 9 Jan 2017.